Drug development for the treatment of RyR1-related skeletal muscle diseases

被引：9

作者：

Murayama, Takashi ^{[1
]}

Kurebayashi, Nagomi ^{[1
]}

Ishida, Ryosuke ^{[2
]}

Kagechika, Hiroyuki ^{[2
]}

机构：

[1] Juntendo Univ, Dept Pharmacol, Sch Med, Tokyo, Japan

[2] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan

来源：

CURRENT OPINION IN PHARMACOLOGY | 2023年 / 69卷

关键词：

CENTRAL CORE DISEASE; MALIGNANT HYPERTHERMIA; RYANODINE RECEPTOR; CALCIUM-RELEASE; CONGENITAL MYOPATHIES; MOLECULAR-MECHANISM; DANTROLENE; RYR1; CHANNEL; MUTATIONS;

D O I：

10.1016/j.coph.2023.102356

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Type 1 ryanodine receptor (RyR1) is an intracellular Ca2+ release channel on the sarcoplasmic reticulum of skeletal muscle, and it plays a central role in excitation-contraction (E-C) coupling. Mutations in RyR1 are implicated in various muscle diseases including malignant hyperthermia, central core disease, and myopathies. Currently, no specific treatment exists for most of these diseases. Recently, high-throughput screening (HTS) assays have been developed for identifying potential candidates for treating RyR-related muscle diseases. Currently, two different methods, namely a FRET-based assay and an endoplasmic reticulum Ca2+-based assay, are avail-able. These assays identified several compounds as novel RyR1 inhibitors. In addition, the development of a reconstituted platform permitted HTS assays for E-C coupling modulators. In this review, we will focus on recent progress in HTS assays and discuss future perspectives of these promising approaches.

引用

页数：7

共 50 条

[31] Therapies for RYR1-Related Myopathies: Where We Stand and the Perspec-tives [J].

Beaufils, Mathilde ;

Travard, Lauriane ;

Rendu, John ;

Marty, Isabelle .

CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (01) :15-25

[32] Genotype-phenotype correlations in recessive RYR1-related myopathies [J].

Kimberly Amburgey ;

Angela Bailey ;

Jean H Hwang ;

Mark A Tarnopolsky ;

Carsten G Bonnemann ;

Livija Medne ;

Katherine D Mathews ;

James Collins ;

Jasper R Daube ;

Gregory P Wellman ;

Brian Callaghan ;

Nigel F Clarke ;

James J Dowling .

Orphanet Journal of Rare Diseases, 8

[33] "Human Stress Syndrome" and the Expanding Spectrum of RYR1-Related Myopathies [J].

Snoeck, M. ;

Treves, S. ;

Molenaar, J. P. ;

Kamsteeg, E. J. ;

Jungbluth, H. ;

Voermans, N. C. .

CELL BIOCHEMISTRY AND BIOPHYSICS, 2016, 74 (01) :85-87

[34] RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine [J].

Illingworth, M. A. ;

Main, M. ;

Pitt, M. ;

Feng, L. ;

Sewry, C. A. ;

Gunny, R. ;

Vorstman, E. ;

Beeson, D. ;

Manzur, A. ;

Muntoni, F. ;

Robb, S. A. .

NEUROMUSCULAR DISORDERS, 2014, 24 (08) :707-712

[35] Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis [J].

de Lima Silva, Elis Vanessa ;

Donis, Karina Carvalho ;

Camara Machado, Fabiana Rita ;

Medeiros, Leonardo Simao ;

de Moura Aschoff, Carlos Alberto ;

Moura de Souza, Carolina Fischinger ;

Poswar, Fabiano de Oliveira ;

Morales Saute, Jonas Alex .

JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (06) :1145-1149

[36] Long-term Natural History of Pediatric Dominant and Recessive RYR1-Related Myopathy [J].

Sarkozy, Anna ;

Sa, Mario ;

Ridout, Deborah ;

Fernandez-Garcia, Miguel Angel ;

Distefano, Maria Grazia ;

Main, Marion ;

Sheehan, Jennie ;

Manzur, Adnan Y. ;

Munot, Pinki ;

Robb, Stephanie ;

Wraige, Elizabeth ;

Quinlivan, Rosaline ;

Scoto, Mariacristina ;

Baranello, Giovanni ;

Gowda, Vasantha ;

Mein, Rachael ;

Phadke, Rahul ;

Jungbluth, Heinz ;

Muntoni, Francesco .

NEUROLOGY, 2023, 101 (15) :E1495-E1508

[37] Novel Variants in Individuals with RYR1-Related Congenital Myopathies: Genetic, Laboratory, and Clinical Findings [J].

Todd, Joshua J. ;

Razaqyar, Muslima S. ;

Witherspoon, Jessica W. ;

Lawal, Tokunbor A. ;

Mankodi, Ami ;

Chrismer, Irene C. ;

Allen, Carolyn ;

Meyer, Mary D. ;

Kuo, Anna ;

Shelton, Monique S. ;

Amburgey, Kim ;

Niyazov, Dmitriy ;

Fequiere, Pierre ;

Bonnemann, Carsten G. ;

Dowling, James J. ;

Meilleur, Katherine G. .

FRONTIERS IN NEUROLOGY, 2018, 9

[38] Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial [J].

Todd, Joshua J. ;

Lawal, Tokunbor A. ;

Chrismer, Irene C. ;

Kokkinis, Angela ;

Grunseich, Christopher ;

Jain, Minal S. ;

Waite, Melissa R. ;

Biancavilla, Victoria ;

Pocock, Shavonne ;

Brooks, Kia ;

Mendoza, Christopher J. ;

Norato, Gina ;

Cheung, Ken ;

Riekhof, Willa ;

Varma, Pooja ;

Colina-Prisco, Claudia ;

Emile-Backer, Magalie ;

Meilleur, Katherine G. ;

Marks, Andrew R. ;

Webb, Yael ;

Marcantonio, Eugene E. ;

Foley, A. Reghan ;

Boennemann, Carsten G. ;

Mohassel, Payam .

ECLINICALMEDICINE, 2024, 68

[39] Compound Heterozygous RYR1 Variants in a Patient with Severe Congenital Myopathy: Case Report and Comparison with Additional Cases of Recessive RYR1-Related Myopathy [J].

Janssen, Soeren ;

Erbe, Leoni S. ;

Kneifel, Moritz ;

Vorgerd, Matthias ;

Doering, Kristina ;

Lubieniecki, Krzysztof P. ;

Lubieniecka, Joanna M. ;

Gerding, Wanda M. ;

Casadei, Nicolas ;

Guettsches, Anne-Katrin ;

Heyer, Christoph ;

Luecke, Thomas ;

Nguyen, Hoa Huu Phuc ;

Koehler, Cornelia ;

Hoffjan, Sabine .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)

[40] Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies [J].

Todd, Joshua J. ;

Lawal, Tokunbor A. ;

Witherspoon, Jessica W. ;

Chrismer, Irene C. ;

Razaqyar, Muslima S. ;

Punjabi, Monal ;

Elliott, Jeffrey S. ;

Tounkara, Fatoumata ;

Kuo, Anna ;

Shelton, Monique O. ;

Allen, Carolyn ;

Cosgrove, Mary M. ;

Linton, Melody ;

Michael, Darren ;

Jain, Minal S. ;

Waite, Melissa ;

Drinkard, Bart ;

Wakim, Paul G. ;

Dowling, James J. ;

Bonnemann, Carsten G. ;

Emile-Backer, Magalie ;

Meilleur, Katherine G. .

NEUROLOGY, 2020, 94 (13) :E1434-E1444

← 1 2 3 4 5 →